查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088184

急性復健市場：2026-2032年全球市場預測（按服務類型、疾病類型、階段類型、設備類型、患者年齡層、提供者類型和最終用戶分類）

Acute Rehabilitation Market by Service Type, Disease Type, Phase Type, Device Type, Patient Age Group, Provider Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，急性復健市場將成長至 1,009.4 億美元，複合年成長率為 7.91%。

主要市場統計數據
基準年 2025 592.1億美元
預計年份：2026年 636.9億美元
預測年份 2032 1009.4億美元
複合年成長率 (%) 7.91%

隨著醫療系統應對中風、創傷、整形外科、心臟病、呼吸系統疾病、神經系統疾病和複雜疾病等日益成長的復健需求，急性期復健正成為現代急性後期護理的核心支柱。包括世界衛生組織（WHO）、經濟合作暨發展組織（ OECD）、美國疾病控制與預防中心（CDC）、美國醫療保險和醫療補助服務中心（CMS）以及各國衛生署一致指出，人口老齡化、急性後期疾病生存率的提高以及慢性病的長期共存，正推動著對協調的住院康復、早期體育活動、多學科護理和成長的功能恢復。

該領域的策略價值直接體現在許多方面，例如減少可避免的再入院、縮短不必要的住院時間、恢復患者的獨立生活能力以及提高重病或受傷後的生活品質。急性復健市場不再僅僅以醫院床位數量來定義，而是取決於醫療資源的可及性、病情嚴重程度的管理、循證臨床路徑、與保險公司的合作、數位轉型、醫護人員的韌性以及展現以患者為中心的功能改善的能力。

急性復健領域的變革性變化

急性復健領域正從以數量為導向的服務模式轉向以課責、主導的照護模式。醫院和復健機構越來越需要記錄患者的功能改善、出院準備、再入院風險、住院效率以及護理過渡。在美國，醫療保健服務中心 (CMS) 的品質報告和基於價值的報銷方案進一步強調了標準化指標的重要性。同時，歐洲、日本、澳洲和加拿大也面臨類似的品質改進和成本控制壓力。

人工智慧在急性復健中的累積影響

人工智慧正透過預測分析、電腦視覺、自然語言處理、機器人技術、遠端監控和工作流程自動化等方式，開始對急性復健產生影響。數據驅動的應用案例包括識別再入院高風險患者、預測出院需求、支持防跌倒方案、最佳化復健計劃，以及利用感測器和影像工具分析患者的活動能力和步態模式。

關鍵區域洞察：主要市場對急性復健的需求

北美仍然是一個成熟的急性復健市場，這得益於完善的住院復健機構、大規模綜合醫療保健系統、品質報告體係以及保險公司對急性期後復健結果的重視。美國在中風復健、脊髓損傷復健、創傷性腦損傷復健以及複雜疾病復健方面擁有特別豐富的經驗，而加拿大則專注於公共資金支持的復健服務、社區復健計畫以及患者出院後的持續復健。

針對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵群體特定見解

為因應人口老化和非傳染性疾病的增加，東南亞國協正努力加強復健體系建設。儘管新加坡、泰國、馬來西亞、印尼、越南和菲律賓的進展速度不盡相同，但全部區域是明確的：提供旨在恢復功能和減少長期依賴的復健服務，對於擴大急性護理至關重要。

各國急性復健服務成長和普及情況的關鍵洞察。

美國在專業住院復健、高級急性後期分析和保險公司主導的品質評估方面發揮主導作用，而加拿大則強調公平獲取醫療服務和省際合作。在墨西哥和巴西，由於都市區醫院的擴張、慢性病、交通事故傷害以及私人醫療保健參與度的提高，需求正在成長。

為急性復健領域的領導者提供的實用建議

行業領導者應優先考慮針對高需求疾病（例如中風、創傷性腦損傷、脊髓損傷、關節重建、心血管事件、肺部疾病以及複雜的康復過程）的循證護理路徑。標準化評估、治療強度、出院計畫、看護者訓練和隨訪，既能改善治療效果，也能增強支付方的信心。

急性復健市場分析的調查方法

本執行摘要基於結構化的初級和二級研究方法。二級研究資訊來源，例如世界衛生組織（WHO）、經濟合作暨發展組織（OECD）、世界銀行、CMS、CDC、歐盟統計局、各國衛生署、康復醫學協會、同行檢驗的學術期刊、醫院品質資訊來源、監管文件和公共保險機構框架。

結論：急性康復的未來

急性期復健正日益成為醫療保健系統運作的核心，因為它關係到急性疾病後的生存、功能恢復、獨立生活能力以及長期成本控制。人口老化、慢性病盛行率上升、創傷和神經系統疾病負擔加重，以及人們對急性期後可衡量療效的期望不斷提高，都推動了這項需求的成長。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 急性復健市場：依服務類型分類

  • 心臟復健
    • 心血管手術後治療
    • 心肌梗塞後的康復
  • 神經復健
    • 中風復健
    • 創傷性腦損傷康復
  • 職業療法
  • 整形外科復健
  • 物理治療
    • 平衡與協調療法
    • 移動訓練
    • 肌力和耐力訓練
  • 肺康復
  • 語言治療

第8章 急性復健市場：依疾病類型分類

  • 心律不整
  • 心絞痛
  • 心房顫動
  • 膽固醇管理
  • 冠狀動脈繞道術
  • 冠狀動脈疾病或周邊動脈疾病
  • 糖尿病
  • 心臟衰竭或移植
  • 高血壓
  • 肺動脈高壓

第9章：急性復健市場：依階段類型分類

  • 第一階段（急性期）
  • 第二階段（亞急性期）
  • 第三階段（長期）
  • 第四階段（社會重返）

第10章：急性復健市場：依設備類型分類

  • 認知和語言支援設備
  • 行動輔助設備
  • 監控工具
  • 物理治療設備
  • 機器人設備

第11章 急性復健市場：依患者年齡層別分類

  • 成人
  • 老年人
  • 兒童

第12章 急性復健市場：依服務提供者類型分類

  • 居家康復
  • 醫院
  • 住院急性護理復健中心
  • 門診復健

第13章 急性復健市場：依最終用戶分類

  • 政府和公共衛生機構
  • 醫療服務提供方
  • 病人

第14章 急性復健市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章 急性復健市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 急性復健市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Acadia Healthcare Company, Inc.
  • Amedisys, Inc.
  • Athena Health Care Systems
  • Aurora Behavioral Health System
  • Cambridge Medical and Rehabilitation Center
  • CareOne Management, LLC by New Frontier Energy, Inc.
  • ClearSky Health
  • Covenant Care
  • Ekso Bionics Holdings, Inc.
  • Encompass Health Corporation
  • Five Star Senior Living by AlerisLife Inc.
  • Genesis Healthcare, Inc.
  • HCA Healthcare, Inc.
  • LHC Group, Inc. by UnitedHealth Group Incorporated
  • LifePoint Health, Inc.
  • National Healthcare Corporation
  • Nexion Health, Inc.
  • Oceans Healthcare
  • Paradigm Healthcare
  • Promises Behavioral Health, LLC
  • Select Medical Corporation
  • St. Ann's Community
  • Tenet Healthcare Corporation
  • The Alden Network
  • The Ensign Group, Inc.
  • Universal Health Services Inc.
Product Code: MRR-0376B2CAB000

The Acute Rehabilitation Market is projected to grow by USD 100.94 billion at a CAGR of 7.91% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 59.21 billion
Estimated Year [2026] USD 63.69 billion
Forecast Year [2032] USD 100.94 billion
CAGR (%) 7.91%

Acute rehabilitation is becoming a core pillar of modern post-acute care as health systems manage rising stroke, trauma, orthopedic, cardiac, pulmonary, neurological, and complex medical recovery needs. Verified public-health sources, including the World Health Organization, OECD, CDC, CMS, and national health ministries, consistently show that aging populations, higher survival after acute events, and longer life with chronic disease are increasing demand for coordinated inpatient rehabilitation, early mobilization, multidisciplinary therapy, and measurable functional recovery.

The sector's strategic value is tied to outcomes: reducing avoidable readmissions, shortening unnecessary hospital stays, restoring independence, and improving quality of life after major illness or injury. The acute rehabilitation market is no longer defined only by bed capacity; it is defined by access, acuity management, evidence-based clinical pathways, payer alignment, digital enablement, workforce resilience, and the ability to demonstrate patient-centered functional gains.

Transformative Shifts in the Acute Rehabilitation Landscape

The acute rehabilitation landscape is shifting from volume-based service delivery toward accountable, outcomes-driven care. Hospitals and rehabilitation providers are increasingly expected to document functional improvement, discharge readiness, readmission risk, length of stay efficiency, and care transitions. In the United States, CMS quality reporting and value-based reimbursement have reinforced the importance of standardized measures, while similar quality and cost-containment pressures are visible across Europe, Japan, Australia, and Canada.

Clinical complexity is also rising. Patients entering acute rehabilitation often present with multimorbidity, frailty, cognitive impairment, polypharmacy, and social determinants that affect recovery. This is accelerating demand for integrated physician-led rehabilitation teams, specialized nursing, physical therapy, occupational therapy, speech-language pathology, respiratory therapy, nutrition support, behavioral health, and caregiver education.

A second major shift is the expansion of hybrid rehabilitation models. Inpatient rehabilitation facilities, hospital-based rehabilitation units, skilled nursing settings, outpatient therapy networks, and home-based digital rehabilitation are becoming more connected. The winners in this landscape will be organizations that can coordinate care across settings while proving safety, intensity, and continuity.

Cumulative Impact of Artificial Intelligence on Acute Rehabilitation

Artificial intelligence is beginning to influence acute rehabilitation through predictive analytics, computer vision, natural language processing, robotics, remote monitoring, and workflow automation. Data-backed use cases include identifying patients at elevated readmission risk, forecasting discharge needs, supporting fall-prevention protocols, optimizing therapy scheduling, and analyzing mobility or gait patterns through sensors and video-enabled tools.

AI's cumulative impact is expected to be operational as much as clinical. Rehabilitation providers face persistent workforce shortages documented by health labor agencies and professional associations. AI-enabled documentation support, automated coding checks, clinical decision support, and capacity planning can reduce administrative burden and help clinicians spend more time on direct patient care.

However, adoption must remain evidence-led. AI tools in acute rehabilitation require transparent validation, bias monitoring, cybersecurity safeguards, human oversight, and compliance with health data regulations such as HIPAA, GDPR, and local privacy frameworks. The strongest organizations will treat AI as a governed clinical support layer, not a replacement for expert rehabilitation judgment.

Key Regional Insights: Acute Rehabilitation Demand Across Major Markets

North America remains a mature acute rehabilitation market, supported by established inpatient rehabilitation facilities, large integrated health systems, quality reporting infrastructure, and payer focus on post-acute outcomes. The United States has particularly strong specialization in stroke rehabilitation, spinal cord injury rehabilitation, traumatic brain injury rehabilitation, and medically complex recovery, while Canada emphasizes publicly funded access, regional rehabilitation planning, and continuity after acute hospital discharge.

Europe benefits from universal or near-universal health coverage models, strong rehabilitation medicine traditions, and structured post-stroke and orthopedic recovery pathways. Germany, France, Italy, Spain, and the United Kingdom each show demand linked to aging demographics and pressure to reduce acute hospital bed occupancy. Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN markets invest in hospital modernization, neurorehabilitation, geriatric care, and medical technology adoption.

Latin America, the Middle East, and Africa present uneven but important opportunities for acute rehabilitation access improvement. Brazil and Mexico anchor Latin American demand through large urban hospital systems, road traffic injury burden, and rising chronic disease prevalence. GCC countries in the Middle East are investing in specialty hospitals, medical tourism, and advanced rehabilitation infrastructure. Across Africa, need is substantial due to trauma, stroke, infectious disease sequelae, and disability burden, but access remains constrained by workforce, financing, and facility capacity.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN countries are strengthening rehabilitation capacity as populations age and noncommunicable diseases become more prevalent. Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines are advancing at different speeds, but the regional direction is clear: acute care expansion must be paired with rehabilitation services that restore function and reduce long-term dependency.

The GCC is positioning rehabilitation as part of broader healthcare transformation, with Saudi Arabia, the United Arab Emirates, Qatar, and other member states investing in specialty care, digital health, and internationally benchmarked hospital services. In the European Union, cross-country differences remain, but EU health priorities around aging, disability inclusion, digital health, and workforce planning support continued rehabilitation modernization.

BRICS countries represent large-scale acute rehabilitation demand driven by population size, urbanization, chronic disease, trauma, and expanding tertiary care systems. G7 markets are more mature and focus heavily on quality, reimbursement discipline, technology integration, and workforce productivity. NATO countries, while diverse, also maintain demand connected to trauma care, military medicine, veterans' rehabilitation, and emergency preparedness.

Key Country Insights for Acute Rehabilitation Growth and Access

The United States leads in specialized inpatient rehabilitation, advanced post-acute analytics, and payer-driven quality measurement, while Canada emphasizes equitable access and provincial coordination. Mexico and Brazil show rising demand from urban hospital expansion, chronic disease, road traffic injuries, and growing private healthcare participation.

In Europe, the United Kingdom is focused on NHS capacity, stroke recovery pathways, and community-based rehabilitation integration. Germany has a highly developed rehabilitation infrastructure and strong statutory insurance role. France, Italy, and Spain continue to align rehabilitation with aging population needs, orthopedic recovery, and neurological care. Russia maintains demand for trauma, neurological, and post-surgical rehabilitation, though access and modernization vary by region.

In Asia-Pacific, China's aging population and hospital expansion are creating major rehabilitation demand, while India faces a large unmet need across stroke, trauma, orthopedic, and neurological recovery. Japan is one of the world's most advanced aging societies, making rehabilitation central to long-term function and independence. Australia combines public and private rehabilitation capacity with strong clinical governance, while South Korea is advancing digital health, robotics, and specialized rehabilitation services.

Actionable Recommendations for Acute Rehabilitation Leaders

Industry leaders should prioritize evidence-based care pathways for high-demand conditions such as stroke, traumatic brain injury, spinal cord injury, joint replacement, cardiac events, pulmonary disease, and medically complex recovery. Standardizing assessment, therapy intensity, discharge planning, caregiver training, and follow-up can improve outcomes while strengthening payer confidence.

Providers should invest in workforce resilience through interdisciplinary staffing models, clinician education, retention programs, and technology that reduces administrative burden. Partnerships with acute hospitals, accountable care organizations, payers, home health providers, and outpatient therapy networks can improve patient flow and reduce fragmented transitions.

Build a measured digital strategy. Remote monitoring, AI-supported risk prediction, robotics, tele-rehabilitation, and patient engagement platforms should be implemented with clear clinical governance, measurable ROI, cybersecurity controls, and equity safeguards to ensure digital rehabilitation benefits all patient groups.

Research Methodology for Acute Rehabilitation Market Analysis

This executive summary is based on a structured secondary and primary research approach. Secondary inputs include verified sources such as the World Health Organization, OECD, World Bank, CMS, CDC, Eurostat, national health ministries, rehabilitation medicine associations, peer-reviewed journals, hospital quality reports, regulatory documents, and public payer frameworks.

Primary research inputs are typically validated through discussions with healthcare, rehabilitation clinicians, hospital administrators, technology vendors, payers, and policy experts. Findings are triangulated across epidemiology, demographics, reimbursement policy, provider capacity, clinical guidelines, technology adoption, and regional healthcare infrastructure.

The analysis avoids unsupported market claims and emphasizes verifiable demand drivers, observable policy shifts, and evidence-backed operational trends. This methodology supports practical decision-making for providers, investors, payers, medical technology companies, and digital health leaders active in acute rehabilitation.

Conclusion: The Future of Acute Rehabilitation

Acute rehabilitation is moving to the center of health system performance because it connects survival after acute illness with functional recovery, independence, and long-term cost control. Demand is supported by aging populations, higher chronic disease prevalence, trauma and neurological burden, and growing expectations for measurable post-acute outcomes.

The next phase of leadership will depend on integrated care models, specialized clinical capability, disciplined quality measurement, workforce sustainability, and responsible digital transformation. Organizations that combine evidence-based rehabilitation medicine with data-driven operations and patient-centered access will be best positioned to improve outcomes and compete in the global acute rehabilitation market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Acute Rehabilitation Market, by Service Type

  • 7.1. Cardiac Rehabilitation
    • 7.1.1. Post Cardiac Surgery Therapy
    • 7.1.2. Post Heart Attack Rehabilitation
  • 7.2. Neurological Rehabilitation
    • 7.2.1. Stroke Rehabilitation
    • 7.2.2. Traumatic Brain Injury Rehabilitation
  • 7.3. Occupational Therapy
  • 7.4. Orthopedic Rehabilitation
  • 7.5. Physical Therapy
    • 7.5.1. Balance and Coordination Therapy
    • 7.5.2. Mobility Training
    • 7.5.3. Strength and Endurance Training
  • 7.6. Pulmonary Rehabilitation
  • 7.7. Speech & Language Therapy

8. Acute Rehabilitation Market, by Disease Type

  • 8.1. Abnormal Heart Rhythms
  • 8.2. Angina
  • 8.3. Atrial Fibrillation
  • 8.4. Cholesterol Management
  • 8.5. Coronary Artery Bypass Surgery
  • 8.6. Coronary or Peripheral Artery Disease
  • 8.7. Diabetes
  • 8.8. Heart Failure or Transplant
  • 8.9. High Blood Pressure
  • 8.10. Pulmonary Hypertension

9. Acute Rehabilitation Market, by Phase Type

  • 9.1. Phase I (Acute)
  • 9.2. Phase II (Sub-acute)
  • 9.3. Phase III (Long-term)
  • 9.4. Phase IV (Reintegration)

10. Acute Rehabilitation Market, by Device Type

  • 10.1. Cognitive/Speech Devices
  • 10.2. Mobility Devices
  • 10.3. Monitoring Tools
  • 10.4. Physio Equipment
  • 10.5. Robotic Devices

11. Acute Rehabilitation Market, by Patient Age Group

  • 11.1. Adults
  • 11.2. Geriatrics
  • 11.3. Pediatrics

12. Acute Rehabilitation Market, by Provider Type

  • 12.1. Home Based Rehabilitation
  • 12.2. Hospitals
  • 12.3. Inpatient Acute Rehabilitation Centers
  • 12.4. Outpatient Rehabilitation

13. Acute Rehabilitation Market, by End User

  • 13.1. Government & Public Health Agencies
  • 13.2. Healthcare Providers
  • 13.3. Patients

14. Acute Rehabilitation Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Acute Rehabilitation Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Acute Rehabilitation Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Acadia Healthcare Company, Inc.
  • 18.2. Amedisys, Inc.
  • 18.3. Athena Health Care Systems
  • 18.4. Aurora Behavioral Health System
  • 18.5. Cambridge Medical and Rehabilitation Center
  • 18.6. CareOne Management, LLC by New Frontier Energy, Inc.
  • 18.7. ClearSky Health
  • 18.8. Covenant Care
  • 18.9. Ekso Bionics Holdings, Inc.
  • 18.10. Encompass Health Corporation
  • 18.11. Five Star Senior Living by AlerisLife Inc.
  • 18.12. Genesis Healthcare, Inc.
  • 18.13. HCA Healthcare, Inc.
  • 18.14. LHC Group, Inc. by UnitedHealth Group Incorporated
  • 18.15. LifePoint Health, Inc.
  • 18.16. National Healthcare Corporation
  • 18.17. Nexion Health, Inc.
  • 18.18. Oceans Healthcare
  • 18.19. Paradigm Healthcare
  • 18.20. Promises Behavioral Health, LLC
  • 18.21. Select Medical Corporation
  • 18.22. St. Ann's Community
  • 18.23. Tenet Healthcare Corporation
  • 18.24. The Alden Network
  • 18.25. The Ensign Group, Inc.
  • 18.26. Universal Health Services Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACUTE REHABILITATION MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ACUTE REHABILITATION MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ACUTE REHABILITATION MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ACUTE REHABILITATION MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE REHABILITATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ACUTE REHABILITATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL POST CARDIAC SURGERY THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL POST CARDIAC SURGERY THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL POST CARDIAC SURGERY THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL POST HEART ATTACK REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL POST HEART ATTACK REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL POST HEART ATTACK REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGICAL REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGICAL REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGICAL REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL STROKE REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL STROKE REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STROKE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL TRAUMATIC BRAIN INJURY REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL TRAUMATIC BRAIN INJURY REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL TRAUMATIC BRAIN INJURY REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OCCUPATIONAL THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OCCUPATIONAL THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OCCUPATIONAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ORTHOPEDIC REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ORTHOPEDIC REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ORTHOPEDIC REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHYSICAL THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHYSICAL THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHYSICAL THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BALANCE AND COORDINATION THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BALANCE AND COORDINATION THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BALANCE AND COORDINATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MOBILITY TRAINING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MOBILITY TRAINING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MOBILITY TRAINING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL STRENGTH AND ENDURANCE TRAINING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL STRENGTH AND ENDURANCE TRAINING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL STRENGTH AND ENDURANCE TRAINING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PULMONARY REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PULMONARY REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PULMONARY REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SPEECH & LANGUAGE THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SPEECH & LANGUAGE THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SPEECH & LANGUAGE THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ABNORMAL HEART RHYTHMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ABNORMAL HEART RHYTHMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ABNORMAL HEART RHYTHMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANGINA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANGINA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANGINA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CHOLESTEROL MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CHOLESTEROL MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CHOLESTEROL MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY ARTERY BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY ARTERY BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY ARTERY BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY OR PERIPHERAL ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY OR PERIPHERAL ARTERY DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY OR PERIPHERAL ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DIABETES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIABETES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DIABETES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEART FAILURE OR TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HEART FAILURE OR TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEART FAILURE OR TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HIGH BLOOD PRESSURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIGH BLOOD PRESSURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HIGH BLOOD PRESSURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PULMONARY HYPERTENSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PULMONARY HYPERTENSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PULMONARY HYPERTENSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHASE I (ACUTE) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHASE I (ACUTE) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHASE I (ACUTE) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHASE II (SUB-ACUTE) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHASE II (SUB-ACUTE) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHASE II (SUB-ACUTE) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHASE III (LONG-TERM) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHASE III (LONG-TERM) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHASE III (LONG-TERM) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHASE IV (REINTEGRATION) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHASE IV (REINTEGRATION) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHASE IV (REINTEGRATION) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL COGNITIVE/SPEECH DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL COGNITIVE/SPEECH DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL COGNITIVE/SPEECH DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MOBILITY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MOBILITY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MOBILITY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MONITORING TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MONITORING TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MONITORING TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHYSIO EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PHYSIO EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PHYSIO EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ROBOTIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ROBOTIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ROBOTIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ADULTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ADULTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ADULTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GERIATRICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GERIATRICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GERIATRICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PEDIATRICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PEDIATRICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PEDIATRICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HOME BASED REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HOME BASED REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HOME BASED REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL INPATIENT ACUTE REHABILITATION CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL INPATIENT ACUTE REHABILITATION CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL INPATIENT ACUTE REHABILITATION CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL OUTPATIENT REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL OUTPATIENT REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL OUTPATIENT REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL GOVERNMENT & PUBLIC HEALTH AGENCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL GOVERNMENT & PUBLIC HEALTH AGENCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL GOVERNMENT & PUBLIC HEALTH AGENCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HEALTHCARE PROVIDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PATIENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PATIENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PATIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. GCC ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. GCC ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 220. GCC ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 221. GCC ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 222. GCC ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. GCC ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. GCC ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. GCC ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. G7 ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 253. G7 ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 254. G7 ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 255. G7 ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. G7 ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. G7 ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. G7 ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 259. G7 ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. G7 ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. NATO ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. NATO ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 264. NATO ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 265. NATO ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 266. NATO ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. NATO ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. NATO ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. NATO ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 270. NATO ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. NATO ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. CANADA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 287. CANADA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 288. CANADA ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 289. CANADA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. CANADA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. CANADA ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. CANADA ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 293. CANADA ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. CANADA ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. MEXICO ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. MEXICO ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. MEXICO ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 298. MEXICO ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 299. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 300. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 304. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. MEXICO ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. BRAZIL ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 309. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 311. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 315. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED KINGDOM ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. GERMANY ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. GERMANY ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. GERMANY ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 331. GERMANY ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 332. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 333. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 334. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 336. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 337. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 338. GERMANY ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 339. FRANCE ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 340. FRANCE ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. FRANCE ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 342. FRANCE ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 343. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
  • TABLE 344. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 345. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 346. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 348. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PROVIDER TYPE, 2018-2032 (USD MILLION)
  • TABLE 349. FRANCE ACUTE REHABILITATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 350. RUSSIA ACUTE REHABILITATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 351. RUSSIA ACUTE REHABILITATION MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. RUSSIA ACUTE REHABILITATION MARKET SIZE, BY CARDIAC REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 353. RUSSIA ACUTE REHABILITATION MARKET SIZE, BY NEUROLOGICAL REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 354. RUSSIA ACUTE REHABILIT